摘要:
There are provided compounds of the formula (I) wherein R1 , R2 , R3 , X, ring A and ring B are as described. The compounds exhibit anticancer properties.
摘要:
The present invention relates to compounds according to formula (1), and pharmaceutically-acceptable salts thereof, wherein R 2 , R 3 , R 4 , R 5 , and R 6 are as defined herein.
摘要:
The present invention relates to compounds of the formula (I-A) medicaments containing them and the use of these compounds as pharmaceutically active agents. The compounds exhibit activity as Raf kinase inhibitors and therefore may be useful for the treatment of diseases mediated by said kinases, especially as anticancer agents.
摘要:
There are provided compounds of the formula (I) wherein R1 , R2 , R3 , X, ring A and ring B are as described. The compounds exhibit anticancer properties.
摘要:
The present invention relates to novel 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid amides of formula (I), and their pharmaceutically acceptable salts and esters which compounds of formula (I) are selective inhibitors of KDR and/or FGFR kinases. These compounds and their pharmaceutically acceptable salts are anti-proliferative agents useful in the treatment or control of solid tumors, in particular solid tumors of the breast, colon, lung and prostate. Also disclosed are pharmaceutical compositions or medicaments containing these compounds, processes for making them and methods of treating cancer using these compounds.